Researchers seeking volunteers for COVID-19 vaccine study

Carmel B. Dyer, MD, speaks to two trial participants at the UTHealth Clinical Research Unit at Memorial Hermann-Texas Medical Center. (Photo by: Roger Castro/UTHealth)

Phase III clinical trial to assess if a potential vaccine is effective at preventing symptomatic COVID-19 is now open for enrollment by The University of Texas Health Science Center at Houston (UTHealth) in collaboration with Memorial Hermann-Texas Medical Center.

The study vaccine, AstraZeneca’s AZD1222, has been shown in early-stage human trials to produce a positive immune response. This trial seeks to enroll 30,000 individuals across the nation. The Houston research site is the UTHealth Clinical Research Unit at Memorial Hermann-Texas Medical Center.

Read the full story, featuring Drs Dyer, Arduino and Lee…

November 2, 2020